About Stuart Peterson
Form D filings for Affect Therapeutics in 2023 list Stuart Peterson as director.
Stuart Peterson first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Stuart Peterson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Stuart Peterson works with at each company, as listed on that company's latest Form D.
Affect Therapeutics, Inc. · Form D, Jul 12, 2023
JR
Jeff Rinehart
Director
KR
Kevin Ryan
Director
JD
Jeff DeFlavio
Director
KM
Kristin Muhlner
Chief Executive Officer and director